95•FAB117-CT-01: Estudio clínico de Fase 1/2 para valorar la viabilidad, seguridad, tolerabilidad y eficacia preliminar de la administración de FAB117-HC
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
